These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25940785)

  • 21. Peroxisome proliferator-activated receptor-γ activation enhances insulin-stimulated glucose disposal by reducing ped/pea-15 gene expression in skeletal muscle cells: evidence for involvement of activator protein-1.
    Ungaro P; Mirra P; Oriente F; Nigro C; Ciccarelli M; Vastolo V; Longo M; Perruolo G; Spinelli R; Formisano P; Miele C; Beguinot F
    J Biol Chem; 2012 Dec; 287(51):42951-61. PubMed ID: 23105093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effect of pioglitazone, a PPARγ ligand, in a 3 nitropropionic acid model of Huntington's disease.
    Napolitano M; Costa L; Palermo R; Giovenco A; Vacca A; Gulino A
    Brain Res Bull; 2011 May; 85(3-4):231-7. PubMed ID: 21440606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of cerebral peroxisome proliferator-activated receptors gamma exerts neuroprotection by inhibiting oxidative stress following pilocarpine-induced status epilepticus.
    Yu X; Shao XG; Sun H; Li YN; Yang J; Deng YC; Huang YG
    Brain Res; 2008 Mar; 1200():146-58. PubMed ID: 18289512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 15-deoxy-Delta12,14 prostaglandin GJ2 but not rosiglitazone regulates metalloproteinase 9, NOS-2, and cyclooxygenase 2 expression and functions by peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms in cardiac cells.
    Hovsepian E; Penas F; Goren NB
    Shock; 2010 Jul; 34(1):60-7. PubMed ID: 19997048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
    Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.
    Zhang YF; Zou XL; Wu J; Yu XQ; Yang X
    Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotrophic Factor-α1/Carboxypeptidase E Functions in Neuroprotection and Alleviates Depression.
    Xiao L; Loh YP
    Front Mol Neurosci; 2022; 15():918852. PubMed ID: 35711734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats.
    Zhao Y; Patzer A; Herdegen T; Gohlke P; Culman J
    FASEB J; 2006 Jun; 20(8):1162-75. PubMed ID: 16770015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of rosiglitazone on peroxisome proliferator activated receptor-γ pathway in patients with chronic obstructive pulmonary disease].
    Zeng XL; Liu XJ; Bao HR; Zhang Y; Tan EL; Liao JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Oct; 34(10):743-8. PubMed ID: 22321707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosiglitazone up-regulates glial fibrillary acidic protein via HB-EGF secreted from astrocytes and neurons through PPARγ pathway and reduces apoptosis in high-fat diet-fed mice.
    Kushwaha R; Mishra J; Gupta AP; Gupta K; Vishwakarma J; Chattopadhyay N; Gayen JR; Kamthan M; Bandyopadhyay S
    J Neurochem; 2019 Jun; 149(5):679-698. PubMed ID: 30311190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke.
    Sobrado M; Pereira MP; Ballesteros I; Hurtado O; Fernández-López D; Pradillo JM; Caso JR; Vivancos J; Nombela F; Serena J; Lizasoain I; Moro MA
    J Neurosci; 2009 Mar; 29(12):3875-84. PubMed ID: 19321784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells.
    Yin Y; Hou G; Li ER; Wang QY; Kang J
    Respirology; 2013 Nov; 18 Suppl 3():30-9. PubMed ID: 24188201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
    Sommer M; Wolf G
    Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive enhancement with rosiglitazone links the hippocampal PPARγ and ERK MAPK signaling pathways.
    Denner LA; Rodriguez-Rivera J; Haidacher SJ; Jahrling JB; Carmical JR; Hernandez CM; Zhao Y; Sadygov RG; Starkey JM; Spratt H; Luxon BA; Wood TG; Dineley KT
    J Neurosci; 2012 Nov; 32(47):16725-35a. PubMed ID: 23175826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rosiglitazone enhances fluorouracil-induced apoptosis of HT-29 cells by activating peroxisome proliferator-activated receptor gamma.
    Zhang YQ; Tang XQ; Sun L; Dong L; Qin Y; Liu HQ; Xia H; Cao JG
    World J Gastroenterol; 2007 Mar; 13(10):1534-40. PubMed ID: 17461445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotection by rosiglitazone in transient focal cerebral ischemia might not be mediated by glutamate transporter-1.
    Verma R; Mishra V; Gupta K; Sasmal D; Raghubir R
    J Neurosci Res; 2011 Nov; 89(11):1849-58. PubMed ID: 21826699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rescue of neurons from ischemic injury by peroxisome proliferator-activated receptor-gamma requires a novel essential cofactor LMO4.
    Schock SC; Xu J; Duquette PM; Qin Z; Lewandowski AJ; Rai PS; Thompson CS; Seifert EL; Harper ME; Chen HH
    J Neurosci; 2008 Nov; 28(47):12433-44. PubMed ID: 19020036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PPARγ agonist rosiglitazone is neuroprotective after traumatic spinal cord injury via anti-inflammatory in adult rats.
    Zhang Q; Hu W; Meng B; Tang T
    Neurol Res; 2010 Oct; 32(8):852-9. PubMed ID: 20350367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rosiglitazone synergizes the neuroprotective effects of valproic acid against quinolinic acid-induced neurotoxicity in rats: targeting PPARγ and HDAC pathways.
    Mishra J; Chaudhary T; Kumar A
    Neurotox Res; 2014 Aug; 26(2):130-51. PubMed ID: 24566814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.